Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR).

Khankhel ZS, Dillon RJ, Thosar M, Bruno C, Puzniak L

Open source

DOI
10.1186/s12941-022-00528-0
Published
2022 Oct 3
Container
Annals of clinical microbiology and antimicrobials
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12941-022-00528-0,
  title = {Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR).},
  author = {Khankhel ZS and Dillon RJ and Thosar M and Bruno C and Puzniak L},
  year = {2022},
  journal = {Annals of clinical microbiology and antimicrobials},
  doi = {10.1186/s12941-022-00528-0},
  url = {https://doi.org/10.1186/s12941-022-00528-0}
}

RIS

TY  - JOUR
TI  - Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR).
AU  - Khankhel ZS
AU  - Dillon RJ
AU  - Thosar M
AU  - Bruno C
AU  - Puzniak L
PY  - 2022
JO  - Annals of clinical microbiology and antimicrobials
DO  - 10.1186/s12941-022-00528-0
UR  - https://doi.org/10.1186/s12941-022-00528-0
ER  - 

APA

ZS, K., RJ, D., M, T., C, B., & L, P. (2022). Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR).. Annals of clinical microbiology and antimicrobials. https://doi.org/10.1186/s12941-022-00528-0

Source records